CTRI/2023/03/050175
Not yet recruiting
未知
Evaluation of Optical coherence tomography angiography following use of anti vascular endothelial growth factor in exudative age related macular degeneration
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- MAULANA AZAD MEDICAL COLLEGE
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •PATIENTS OF EXUDATIVE AGE RELATED MACULAR DEGENERATION, WHO ARE ANTI VEGF NAIVE
- •SUBJECTS HAVING BEST CORRECTED VISUAL ACUITY OF AT LEAST 6/60
Exclusion Criteria
- •SUBJECTS HAVING OTHER SIGNIFICANT OCULAR AND SYSTEMIC DISEASES
- •RISK OF THROMBOEMBOLIC EVENTS AND/OR OCCURRENCE OF THESE WITHIN PAST 6 MONTHS
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Evaluation of OCTA following use of Anti VEGF in retinal disease of eye in diabetic patientsHealth Condition 1: H350- Background retinopathy and retinalvascular changesCTRI/2023/04/051257Maulana Azad Medical College
Recruiting
Not Applicable
Optical coherence tomography angiography in healthy subjects and patients with retinal vascular diseases.Retinal vascular diseasesACTRN12617001633370lions eye institute300
Not yet recruiting
Not Applicable
evaluation of OCTA following antiVEGF in patient having retinal disease non resolving central serous chorioretinopathyCTRI/2024/08/072312Maulana Azad Medical college
Not yet recruiting
Phase 4
Evaluation of OCTA after giving AntiVEGF in BRVO patientsCTRI/2024/08/072313Maulana Azad Medical College
Not yet recruiting
Not Applicable
Evaluation of OCTA parameters in CSCRCTRI/2021/09/036966KAVYA C RAO